| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1021157846 |
| P356 | DOI | 10.2165/00128072-200305060-00002 |
| P698 | PubMed publication ID | 12765486 |
| P2093 | author name string | Stephen C Eppes | |
| P2860 | cites work | Treatment of the Early Manifestations of Lyme Disease | Q22241125 |
| Lyme Disease | Q22250902 | ||
| Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease | Q22250903 | ||
| Detection of Borrelia burgdorferi DNA by Polymerase Chain Reaction in Synovial Fluid from Patients with Lyme Arthritis | Q22250914 | ||
| Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans | Q24678610 | ||
| Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis | Q28264393 | ||
| Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group | Q28277088 | ||
| Intralaboratory reliability of serologic and urine testing for Lyme disease | Q33933793 | ||
| Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. | Q33964217 | ||
| Comparison of Cefuroxime Axetil and Doxycycline in the Treatment of Early Lyme Disease | Q33992441 | ||
| Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite | Q34083810 | ||
| Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease | Q34301091 | ||
| Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis | Q34330551 | ||
| Physician beliefs, attitudes, and approaches toward Lyme disease in an endemic area | Q34341882 | ||
| Tetracycline therapy for chronic Lyme disease | Q34433477 | ||
| Teratogen update: Lyme disease | Q34464402 | ||
| Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin | Q34560251 | ||
| Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis | Q34613449 | ||
| Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis | Q35005600 | ||
| Clarithromycin in treatment of early Lyme disease: a pilot study | Q35122553 | ||
| Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents | Q35281053 | ||
| Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi | Q35818085 | ||
| Detection of Borrelia burgdorferi-specific DNA in urine specimens from patients with erythema migrans before and after antibiotic therapy | Q36533514 | ||
| Temporal study of immunoglobin M seroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosis. | Q36543739 | ||
| Demographic differences in notifiable infectious disease morbidity--United States, 1992-1994. | Q38455827 | ||
| In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents | Q39866294 | ||
| Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial | Q40669582 | ||
| Efficacy of antibiotic prophylaxis for prevention of Lyme disease | Q41109026 | ||
| Biliary complications in the treatment of unsubstantiated Lyme disease | Q43212857 | ||
| The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk | Q43663863 | ||
| Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease | Q44013332 | ||
| Cerebrospinal fluid findings in children with Lyme disease-associated facial nerve palsy | Q44045740 | ||
| Long-term outcome of Lyme disease in children given early treatment | Q44223780 | ||
| Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America | Q44628961 | ||
| Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study | Q47581031 | ||
| A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium | Q47625328 | ||
| Environmental and life-style risk factors for Lyme disease in children. | Q51006703 | ||
| Cognitive effects of Lyme disease in children. | Q52057115 | ||
| Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis. | Q53592534 | ||
| Treatment of lyme arthritis | Q59745819 | ||
| Ceftriaxone Compared with Doxycycline for the Treatment of Acute Disseminated Lyme Disease | Q63664757 | ||
| Successful Oral Doxycycline Treatment of Lyme Disease‐Associated Facial Palsy and Meningitis | Q63664761 | ||
| Prevention of Lyme disease after tick bites. A cost-effectiveness analysis | Q67479991 | ||
| Treatment of early lyme disease | Q67487280 | ||
| A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites | Q67582600 | ||
| Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection | Q67755859 | ||
| Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy | Q67925059 | ||
| Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings | Q72971021 | ||
| Antibiotic therapy for Lyme disease in a population-based cohort | Q73104997 | ||
| Facial palsy and Lyme borreliosis: long-term follow-up of children with antibiotically untreated "idiopathic" facial palsy | Q73416265 | ||
| Lyme disease and seventh nerve paralysis in children | Q73662724 | ||
| Test-treatment strategies for patients suspected of having Lyme disease: a cost-effectiveness analysis | Q74023627 | ||
| Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination | Q74062160 | ||
| Doxycycline for tick bites--not for everyone | Q74192365 | ||
| Doxycycline and staining of permanent teeth | Q74615040 | ||
| P433 | issue | 6 | |
| P921 | main subject | Lyme disease | Q201989 |
| P304 | page(s) | 363-372 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Pediatric Drugs | Q15767256 |
| P1476 | title | Diagnosis, treatment, and prevention of Lyme disease in children | |
| P478 | volume | 5 |
| Q43991166 | Acute facial nerve palsy in children: how often is it lyme borreliosis? |
| Q37013981 | All that palsies is not Bell's -the need to define Bell's palsy as an adverse event following immunization. |
| Q46944115 | Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children. |
| Q31103326 | Facial nerve palsy including Bell's palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data |
| Q89152770 | Insights From the Geographic Spread of the Lyme Disease Epidemic |
| Q33413845 | Laboratory data in children with Lyme neuroborreliosis, relation to clinical presentation and duration of symptoms |
| Q42413634 | Oedema of the metatarsal heads II-IV and forefoot pain as an unusual manifestation of Lyme disease: a case report |
| Q34471224 | Review of treatment options for lyme borreliosis |
Search more.